Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (127 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 27 Feb 2026 – 20 Aug 2026, limited by Mirae Asset Nifty Metal ETF FOF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Mirae Asset Nifty Metal ETF FOF | Nifty 500 |
|---|---|---|
| 27 Feb 2026 | ₹100.00 | ₹100.00 |
| 14 Mar 2026 | ₹92.30 | ₹92.34 |
| 28 Mar 2026 | ₹92.08 | ₹90.73 |
| 12 Apr 2026 | ₹101.53 | ₹96.46 |
| 26 Apr 2026 | ₹104.86 | ₹97.42 |
| 11 May 2026 | ₹106.25 | ₹98.40 |
| 25 May 2026 | ₹109.77 | ₹98.98 |
| 09 Jun 2026 | ₹106.82 | ₹96.56 |
| 23 Jun 2026 | ₹104.43 | ₹99.33 |
| 08 Jul 2026 | ₹102.63 | ₹98.88 |
| 22 Jul 2026 | ₹103.60 | ₹99.91 |
| 06 Aug 2026 | ₹108.32 | ₹102.43 |
| 20 Aug 2026 | ₹107.34 | ₹101.49 |
| Metric | Mirae Asset · Direct · IDCW NAV ₹10.57 Very High risk Unrated | Category median FoF Domestic · 127 funds |
|---|---|---|
| — | +6.09% | |
| — | +11.54% | |
| — | +7.95% | |
| — | +9.85% | |
| +7.34% | +8.39% | |
| +15.96% | — | |
| — | +11.20% | |
| — | +9.48% | |
| — | +10.18% | |
| Risk | ||
| 22.64% | 12.96% | |
| — | 0.43 | |
| — | 0.62 | |
| -10.97% | -17.91% | |
| Nifty 500 | — | |
| — | +0.56% | |
| — | 0.95 | |
| — | 95.5% | |
| — | 86.6% | |
| 0.20% | 0.14% | |
| ₹75.71Cr | ₹338.76Cr | |
| 0.05% | — | |
| None | — | |
| ₹99 | — | |
| ₹5.00K | — | |
| — | 14% | |
| Ekta Gala · 0.5y | — | |
| 27 Feb 2026 | — | |
| — | — | |
| — | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.